Skip to main content

Find Clinical Trials

Home
Conditions
Sarcoma

Clinical trial condition

Sarcoma

Explore clinical trials studying Sarcoma. Study availability and eligibility vary by location and protocol.

629 public trials 171 recruiting studies

Refine in advanced search Browse all conditions

Sarcoma trial results

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma

NCT07725783

Conditions: Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Peking University People's Hospital, Beijing, Beijing 100044 Beijing, China

View Trial Details

Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

NCT05333458

Conditions: Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma, +8 more
Locations: Keck Medicine of USC Koreatown Los Angeles, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States

View all 13 locations

View Trial Details

Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions: Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

NCT07211737

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

NCT04303117

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

NCT07297979

Conditions: Disease Attributes, Ewing Sarcoma, Neoplasms, +10 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Precision Imaging to Evaluate Kaposi Sarcoma

NCT06898203

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: Kenya Medical Research Institute Kisumu, Kenya

Infectious Diseases Institute, Makerere University Kampala, Uganda

View Trial Details

Recruiting

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

NCT03093909

Conditions: Bone Diseases, Bone Neoplasms, Female Urogenital Diseases, +34 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667

Conditions: Adenocarcinoma, Alveolar Soft Part Sarcoma, Breast Diseases, +25 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

University Health Network Toronto, Ontario, Canada

View Trial Details